EIR Ventures
Venture capitalStockholm · Seed–Growth · 10 people tracked
Find your way into EIR Ventures
823 people in our graph share verified history with the EIR Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Eir Ventures invests in innovative medicine, backing Nordic life-science innovation intended to advance global health and improve millions of lives while delivering strong returns fund after fund. Its investment approach is built on a triad it applies to every portfolio company: transformative potential, excellence in execution, and scalability. The firm takes an active ownership role, creating companies and holding board seats, chairpersonships, and even CEO roles. It emphasizes translating rapidly evolving scientific innovations into business opportunities and patient benefits, and works with international syndication partners across the Nordics, Europe, and the US.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's website & public directories
What they invest in
from 18 of 24 portfolio companiesBiotech ×15Healthtech ×10Deep Tech ×7Medical Devices ×7AI & Machine Learning ×4Digital Health ×3Longevity ×3SaaS ×2
HQs:Sweden×7United States×3Denmark×1
Investments · 24 tracked
founders shown can be your intro pathBy year:2026 · 12023 · 12020 · 13 dated
Damora Therapeutics is a preclinical-stage biotechnology company that discovers and develops therapeutic candidates, including DMR-001, DMR-002, and DMR-003, with the goal of advancing treatments through investigational drug applications and clinical trials.
BiotechCopenhagen, US
Garrett Winslow(Executive Officer)inLori Firmani(Executive Officer)inHans T. Schambye(Executive Officer, Director)Jennifer Jarrett(President, Chief Executive Officer and Director)inBecker Hewes(Chief Medical Officer)Sherwin Sattarzadeh(Chief Operating Officer)
Board seatStephan Christgau· per SEC Form D · $64.2M raise · filed Nov 2020
Co-investorsAccess BiotechnologyBAM ElevateBay City CapitalCommodore CapitalForbionJanus Henderson Investors+6 more
Moleculent develops biological discovery and disease understanding tools for scientists.
AI & Machine LearningBiotechDeep Tech
Fredrik Roos(CTO & Co-founder)in
Co-investorsARCH Venture Partners
Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.
BiotechDeep TechHealthtechMedical Devices
Michal Minczuk(Co-Founder)inGabriel Martinez(Chief Scientific Officer & Co-Founder)Claes Gustafsson(Co-Founder)Maria Falkenberg(Co-Founder)Nils-Göran Larsson(Co-Founder)Gabriel Martinez, Ph.D.(Chief Scientific Officer & Co-Founder)
Co-investorsARCH Venture PartnersCambridge Innovation CapitalAngelini VenturesGV (Google Ventures)HealthCap
Strike Pharma develops nanoparticle delivery technology to enable the development of in vivo CAR therapies.
BiotechDeep TechHealthtechLongevityMedical DevicesStockholm, SE
Sara Mangsbo(Founder)Johan Rockberg(Co-founder)Per Norlén(Chief Executive Officer)Tina Furebring(Chief Operations Officer)
Co-investorsAlmi Invest
ArgusEye develops LSPR-based biosensor systems for real-time monitoring and analytics of bioprocesses in biopharmaceutical development and manufacturing.
BiotechDeep TechHardware
Co-investorsVoima Ventures
ArgusEye builds autonomous AI engineers for product security in cyber-physical systems, operating inside R&D and engineering teams to model threats, prescribe security controls, and generate audit-ready evidence.
AI & Machine LearningCybersecurityDeep TechSan Francisco, US
Jackson Schultz(Co-founder & CEO)inLawrence Ibarria(Co-Founder & CTO)inW. Jackson Schultz(Co-Founder & CEO)in
Co-investorsCIVPredictive VCVoima Ventures
Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients.
BiotechDigital HealthHealthtechMedical DevicesStockholm, SE
Lars E. Gustafsson(Co-founder (deceased))
BoardMagnus Persson(Chairman of the Board)
Co-investorsHadean Ventures
Cinclus Pharma is a clinical-stage pharmaceutical company developing small molecule treatments for gastric acid-related disorders, with its lead compound targeting severe gastroesophageal reflux disease.
BiotechDigital HealthHealthtechMedical Devices
Christer Ahlberg(CEO)
Entrilia provides an integrated platform supporting the complete lifecycle of fund operations, including financial reporting, investor management, and operational workflows for fund managers.
AI & Machine LearningEnterprise SoftwareFintechSaaS
Co-investorsWatertower Ventures Management, Llc
Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.
BiotechMedical Devices
Jennifer Jarrett(Chief Executive Officer & Board Director)inSherwin Sattarzadeh(Chief Operating Officer)inBecker Hewes(Chief Medical Officer)Garrett Winslow(General Counsel)inJim Baker(Chief Corporate Affairs Officer)inBrian Burkavage(Senior Vice President, Finance)in
Co-investorsHadean VenturesM VenturesSEED Capital DenmarkSunstone CapitalYsios CapitalMaverick Ventures+1 more
Gutcrine is a Danish biotech developing pharmabiotics derived from gut microbiome hormone synthesis, aimed at the prevention and treatment of cardio-metabolic disorders.
BiotechDeep TechHealthtechLongevityCopenhagen, DK
Oluf Pedersen(CSO & Co-founder)Yong Fan(COO & Co-founder)Tobias Horneman-Thielcke(CEO)in
Henlez is an early-stage biotech company working in the dermatology space.
BiotechHealthtech
Jeppe C. Mouritsen, PhD(Founding CEO)Gregor Jemec, MD(Co-founder & Chief Scientific Advisor)
Danish biotech developing non-opioid restorative treatments for chronic pain, hearing loss and sensory neuron disorders.
Co-investorsIndaco Venture PartnersMedical Incubator Japan K.K.
IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.
BiotechMedical Devices
Dr. Dhingra
Co-investorsAvoro Capital AdvisorsKurma PartnersRA CapitalSamsara BioCapitalSunstone CapitalVivo Capital+2 more
Purpose Pharma develops pharmaceutical treatments for rare genetic and metabolic diseases, with a focus on hereditary amyloidosis conditions.
BiotechHealthtechLongevityMedical DevicesStockholm, SE
Jonas Hansson(CEO, Co-founder)Jacob Gunterberg(CFO, Co-founder)Lars Olsson(COO, Co-founder)
Co-investorsIndustrifonden
The page is a domain listing/marketplace tool (ExpiredDomains.com) that aggregates expired and expiring domain names across many TLDs and lets users filter them by SEO authority, keywords, backlinks, and brand potential.
Marketing TechSaaS
SACRA Therapeutics is a drug discovery company developing therapeutics that target the RNA epitranscriptome, with a focus on oncology.
BiotechHealthtechLund, SE
Scenic Biotech develops modifier therapy, a genetic medicine approach that targets secondary functions in the genome to neutralize the impact of disease-causing mutations.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtech
Co-investorsBioMedPartnersOxford Science EnterprisesBioGeneration VenturesInkef
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Cinclus PharmaDania TxPretzelRappSortina
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 IPOsDamora TherapeuticsNASDAQ: DMRA
Portfolio news
latest coverage across their companiesDamora Therapeutics · seekingalpha.com · Sep 15, 2026
Attgeno · hadeanventures.com · May 27, 2026
Moleculent AB · finance.yahoo.com · Apr 30, 2026
IO Biotech · european-biotechnology.com · Apr 2, 2026
Pretzel Therapeutics · nasdaqprivatemarket.com · Aug 3, 2025
Frequently asked questions
- How many investments has EIR Ventures made?
- EIR Ventures has 24 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does EIR Ventures invest at?
- EIR Ventures invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does EIR Ventures focus on?
- EIR Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is EIR Ventures located?
- EIR Ventures is headquartered in Stockholm, SE.
- Does EIR Ventures lead rounds?
- Yes, EIR Ventures leads investment rounds.
- Who does EIR Ventures co-invest with?
- EIR Ventures most often shares deals with ARCH Venture Partners, Hadean Ventures, Sunstone Capital, among 20 tracked co-investors.
Media · Podcasts & interviews
featuring the team12: Investing in Biotech, with Lovisa Backemar, Principal at Eir Ventures
Investing & Other Stories Podcast · Lovisa Backemar
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.